Tempus AI, Inc. (NASDAQ:TEM) CFO Sells $59,057.64 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 1,468 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $40.23, for a total value of $59,057.64. Following the completion of the transaction, the chief financial officer now directly owns 229,812 shares of the company’s stock, valued at $9,245,336.76. This represents a 0.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

James William Rogers also recently made the following trade(s):

• On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The shares were sold at an average price of $42.30, for a total value of $3,511,957.50.

Tempus AI Stock Down 3.7 %

Shares of Tempus AI stock opened at $33.03 on Friday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business has a fifty day moving average of $51.96. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. bought a new stake in Tempus AI during the third quarter valued at about $30,000. Geode Capital Management LLC raised its stake in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after purchasing an additional 539 shares during the period. Vestor Capital LLC purchased a new position in Tempus AI in the 3rd quarter worth approximately $153,000. The Manufacturers Life Insurance Company boosted its stake in Tempus AI by 10.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock worth $1,686,000 after purchasing an additional 2,765 shares during the period. Finally, Stifel Financial Corp bought a new position in Tempus AI in the 3rd quarter worth approximately $218,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TEM. Guggenheim began coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital upped their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Bank of America lifted their price objective on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Finally, Wolfe Research assumed coverage on Tempus AI in a research note on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.